Skip to main content
Conferences and Meetings 603. Lymphoid Oncogenesis: Basic: Poster III

603. Lymphoid Oncogenesis: Basic: Poster III

Short name: updated-603. Lymphoid Oncogenesis: Basic: Poster III-2025 Annual Meeting Poster Bundle Omics & Emerging Technologies
Course start date: 02/18/2026

Sections

General
0 activities

Identification of NAE1 dependent β catenin neddylation as selective vulnerability in B cell malignancies
The NLP protein is a novel regulator of G2 m Phase of the cell cycle critical for proliferation of human peripheral T cell lymphomas
RNA−binding protein FXR1 stabilizes receptor tyrosine kinase FGFR1 and enhances PI3K−Akt signaling to promote T−cell leukemogenesis
CELF2 deficient mutations promote B cell lymphoma development by inducing a germinal center B cell fate
TP53 mutation promotes diffuse large B cell lymphoma progression via mediating lactylation of ATP5E at Lys44
IL 17–Induced CD70 expression promotes T cell suppression in DLBCL Implications for immune escape and T cell exhaustion
Functional analysis of STAT3 activating mutations in LGL leukemia reveals epigenetic reprograming and therapeutic vulnerabilities
PARP1 facilitates transcriptional activity and stability of the BCL6 protein and is a therapeutic target in BCL6 expressing lymphomas
Single cell analysis and functional profiling reveal galectin 3–driven reprogramming of the tumor immune microenvironment in transformed follicular lymphoma
Chromatin remodeler SATB2 thorough Bmi1 PRC1 activity controls transformation and reprogramming of ph B cell progenitors
Cutaneous diffuse large B cell lymphoma induce a macrophage immunosuppressive phenotype through IL 10 secretion

Vimeo Vimeo
11